Rights and permissions
About this article
Cite this article
Hypoglycaemia risk favours nateglinide-based therapy. React. Wkly. 1080, 4 (2005). https://doi.org/10.2165/00128415-200510800-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200510800-00010